Learn More
Invitrogen™ UBE3C Polyclonal Antibody

Description
Immunogen sequence: PISLEDLKSF TNYSGGYSAD HPVIKVFWRV VEGFTDEEKR KLLKFVTSCS RPPLLGFKEL YPAFCIHNGG SDLERLPTAS TCMNLLKLPE FYDETLLRSK LLYAIECAAG FELS Product note: Prior to December 2023, PA5-110540 was manufactured using a Recombinant fusion protein immunogen containing a sequence corresponding to amino acids 1-270 of human UBE3C. The affected lots are: WE3272737, WL3440149, XG3626363, 334B8A30, WH3338145, and VE2999302. Beginning in January 2024, all lots have been produced using a Recombinant fusion protein immunogen containing a sequence corresponding to amino acids 970-1083 of human UBE3C. Refer to the datasheets linked below for lot-specific immunogen information.
Specifications
Specifications
| Antigen | UBE3C |
| Applications | ELISA, Western Blot, Immunocytochemistry |
| Classification | Polyclonal |
| Concentration | 0.81 mg/mL |
| Conjugate | Unconjugated |
| Formulation | PBS with 50% glycerol and 0.02% sodium azide; pH 7.3 |
| Gene | UBE3C |
| Gene Accession No. | Q15386 |
| Gene Alias | AI853514; HectH2; HECT-type ubiquitin transferase E3C; KIAA0010; KIAA10; mKIAA0010; RGD1559986; Ube3c; ubiquitin protein ligase E3C; ubiquitin-protein isopeptide ligase (E3); ubiquitin-protein ligase E3C |
| Gene Symbols | UBE3C |
| Show More |
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.